Transforming Real-World Data Into Evidence-Driven Healthcare Decisions
York HEOR Group provides real-world evidence consulting to pharmaceutical, biotechnology, medical device, and healthcare organizations, generating high-quality real-world evidence, health economics, and outcomes research that informs regulatory, clinical, market access, and commercial decision-making.
Why York HEOR Group
Scientific Expertise
Our multidisciplinary team combines expertise in epidemiology, biostatistics, health economics, outcomes research, and data science.
Advanced Data Experience
Deep experience working with healthcare claims, electronic health records, registries, and linked data environments.
End-to-End Support
From research concept to publication-ready deliverables.
Actionable Insights
Evidence designed to support real-world decisions, not simply generate reports.
Trusted Evidence. Meaningful Outcomes.
Healthcare decisions increasingly depend on real-world evidence that reflects how therapies perform beyond clinical trials. York HEOR Group helps organizations transform complex healthcare data into actionable insights that support product development, market access, reimbursement, regulatory activities, and patient-centered research.
From evidence strategy and study design to advanced analytics and scientific dissemination, we provide end-to-end support throughout the evidence-generation lifecycle.
Our Mission
To improve healthcare decisions through rigorous evidence generation, advanced analytics, and scientific excellence.
Key Questions We Help Answer
Real-world evidence has become a critical component of healthcare decision-making.
- How does treatment perform in routine clinical practice?
- Which patients benefit most from therapy?
- What is the real-world economic impact?
- What outcomes matter most to payers?
- What evidence gaps currently exist?
Our Services
Develop targeted evidence-generation plans that address critical business, regulatory, and clinical questions.
Identify, evaluate, and integrate the right data sources for your research objectives.
Conduct scientifically rigorous retrospective and prospective observational studies.
Generate insights into prevalence, incidence, disease progression, and unmet medical needs.
Demonstrate clinical and economic value to payers, health technology assessment bodies, and healthcare decision-makers.
Deliver advanced statistical analysis and programming support using industry-leading methodologies and platforms.
Data Sources
Administrative Claims
- Diagnoses
- Procedures
- Medications
- Healthcare utilization
- Costs
Electronic Health Records
- Clinical measurements
- Laboratory results
- Vital signs
- Treatment outcomes
Disease Registries
- Longitudinal outcomes
- Clinical characteristics
- Disease progression metrics
Project Workflow
Observational studies provide valuable insights into healthcare delivery and treatment effectiveness in real-world settings.
- Research Question Development
- Protocol Creation
- Cohort Design
- Data Extraction
- Statistical Analysis
- Interpretation
- Publication and Dissemination
Who We Support
York HEOR Group supports research across a diverse range of therapeutic areas.
Supporting Healthcare Stakeholders Across the Ecosystem
- OncologyCancer outcomes, survival analysis, treatment patterns.
- Cardiovascular DiseaseHeart failure, atrial fibrillation, hypertension, and ischemic disease.
- EndocrinologyDiabetes, obesity, and metabolic disorders.
- NeurologyMultiple sclerosis, Alzheimer’s disease, Parkinson’s disease.
- ImmunologyAutoimmune and inflammatory conditions.
- Rare DiseasesNatural history and patient journey studies.
- Respiratory DiseaseAsthma, COPD, and pulmonary disorders.
- Infectious DiseaseTreatment outcomes and healthcare utilization.
- GastroenterologyIBD and gastrointestinal disorders.
- Women’s HealthMaternal health, reproductive medicine, and gynecologic conditions.
- Pharmaceutical CompaniesClinical development, evidence generation, and market access support.
- Biotechnology CompaniesResearch support for emerging therapies and novel treatment approaches.
- Medical Device OrganizationsReal-world performance and outcomes assessment.
- Diagnostics CompaniesClinical utility and economic value demonstration.
- Digital Health OrganizationsPatient engagement, outcomes measurement, and healthcare analytics.
- Payers & Health PlansPopulation health and resource utilization analyses.
- Providers & Health SystemsHealthcare quality improvement and treatment optimization.
- Government & Public HealthDisease surveillance and policy-support research.
Frequently Asked Questions
Whether you need support with evidence generation, epidemiology, outcomes research, health economics, or advanced analytics, York HEOR Group is ready to help.
What is real-world evidence?
Real-world evidence is clinical evidence about the use, benefits, and risks of a medical product, drawn from real-world data such as claims, electronic health records, and registries.
What is HEOR?
HEOR, or health economics and outcomes research, studies the clinical, economic, and patient outcomes of healthcare interventions to show their value to payers and decision-makers.
What is real-world data?
Real-world data is health information collected during routine care rather than in a clinical trial, such as insurance claims, electronic health records, and disease registries.
What is an observational study?
An observational study records what happens to patients in routine care without assigning a treatment. Common designs are cohort, case-control, and cross-sectional studies.
What does York HEOR Group do?
We help life sciences companies generate evidence from real-world healthcare data, from evidence strategy and observational studies to epidemiology, HEOR, and biostatistics.
Ready to unlock the value of your healthcare data?
Connect with York HEOR Group today to build an evidence strategy that supports better healthcare decisions.